• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 06, 2024 at 12:02: PM
via Novo Nordisk (NVO) revealed mixed third quarter results, the pharmaceutical giant narrowing its full-year sales growth guidance while posting a 79% year-over-year sales increase for its landmark weight-loss drug Wegovy.

article source
 






Top Bottom
Back
Quote